Radiofrequency ablation in the management of liver metastases from breast cancer.
OBJECTIVE
Systemic chemotherapy remains the standard treatment for patients with breast cancer hepatic metastases. Resection of metastases has survival advantages in a small percentage of selected patients. Radiofrequency ablation has been used in small numbers of selected patients. This small series was undertaken to review our experience with radiofrequency ablation in the management of patients with breast cancer hepatic metastases.


CONCLUSIONS
Radiofrequency ablation of breast cancer hepatic metastases is safe and may be used to control hepatic deposits in patients with stable or no extrahepatic disease.
Sofocleous
C T
CT
Section of Interventional Radiology and Image Guided Therapies, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., Rm. H118, New York, NY 10021, USA. sofoclec@mskcc.org
Nascimento
R G
RG
Gonen
M
M
Theodoulou
M
M
Covey
A M
AM
Brody
L A
LA
Solomon
S M
SM
Thornton
R
R
Fong
Y
Y
Getrajdman
G I
GI
Brown
K T
KT
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000401:mortality / Q000601:surgery*; D017115:Catheter Ablation / Q000379:methods* / Q000706:statistics & numerical data; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000517:prevention & control*; D009518:New York / Q000453:epidemiology; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D016019:Survival Analysis; D015996:Survival Rate; D016896:Treatment Outcome